Salix To Pay $210M To Settle Stock Inflation Class Action
Shareholders in a proposed class action asked a New York federal court on Friday for preliminary approval of a $210 million settlement to end a lawsuit accusing Salix Pharmaceuticals Ltd. of...To view the full article, register now.
Already a subscriber? Click here to view full article